GB1011013A - Disaggregated gamma globulin and process for preparing it - Google Patents
Disaggregated gamma globulin and process for preparing itInfo
- Publication number
- GB1011013A GB1011013A GB41945/61A GB4194561A GB1011013A GB 1011013 A GB1011013 A GB 1011013A GB 41945/61 A GB41945/61 A GB 41945/61A GB 4194561 A GB4194561 A GB 4194561A GB 1011013 A GB1011013 A GB 1011013A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gamma globulin
- human serum
- disaggregated
- molecular weight
- low molecular
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
A disaggregated human gamma globulin, freed from substances affecting the complement system of human serum and having a sedimentation constant S within the range of from 3.0 to 5.5, is prepared by treating a gamma globulin fraction of human serum, in an aqueous medium at a pH of from 1.5 to 5.5 and at a temperature of from 0 DEG to 50 DEG C., with pepsin until no anti-complement activity (in respect of human serum) is detectable, removing low molecular weight impurities from the disaggregated gamma globulin so obtained, filtering the product under sterile conditions, and, if desired, lyophilising the product so obtained. The removal of the low molecular weight impurities may be achieved, for example, by fractional precipitation with salts or organic solvents or by ultrafiltration. The initial gamma globulin fraction may be one obtained by precipitation from human serum with ammonium sulphate or alcohol.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEB64342A DE1148037B (en) | 1961-10-11 | 1961-10-11 | Process for the production of a disaggregated gamma globulin which does not affect the complement system |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1011013A true GB1011013A (en) | 1965-11-24 |
Family
ID=6974351
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB41945/61A Expired GB1011013A (en) | 1961-10-11 | 1961-11-23 | Disaggregated gamma globulin and process for preparing it |
Country Status (5)
Country | Link |
---|---|
CH (1) | CH397151A (en) |
DE (1) | DE1148037B (en) |
FR (2) | FR1560201A (en) |
GB (1) | GB1011013A (en) |
SE (1) | SE308367B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2001325A (en) * | 1977-07-19 | 1979-01-31 | Green Cross Corp | Gamma globulin preparation |
DE3220309A1 (en) * | 1981-05-29 | 1982-12-16 | Mochida Pharmaceutical Co., Ltd., Tokyo | METHOD FOR PRODUCING (GAMMA) -GLOBULIN FOR INTRAVENOUS INJECTION AND THERAPEUTIC AGENT WHICH CONTAINS THE SAME |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2846412A1 (en) * | 1978-10-25 | 1980-05-08 | Behringwerke Ag | AGENT FOR TREATING ALLERGIC REACTIONS |
AT383739B (en) * | 1983-03-16 | 1987-08-10 | Immuno Ag | METHOD FOR INACTIVATING SUBSTANCES CAUSING INCOMPATIBILITY REACTIONS IN IMMUNALLOBULIN BLOOD FRACTIONS |
-
1961
- 1961-10-11 DE DEB64342A patent/DE1148037B/en active Pending
- 1961-11-20 CH CH1346261A patent/CH397151A/en unknown
- 1961-11-23 GB GB41945/61A patent/GB1011013A/en not_active Expired
- 1961-12-01 SE SE12003/61A patent/SE308367B/xx unknown
-
1962
- 1962-01-09 FR FR1560201D patent/FR1560201A/fr not_active Expired
- 1962-04-06 FR FR893660A patent/FR2382M/en active Active
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2001325A (en) * | 1977-07-19 | 1979-01-31 | Green Cross Corp | Gamma globulin preparation |
DE3220309A1 (en) * | 1981-05-29 | 1982-12-16 | Mochida Pharmaceutical Co., Ltd., Tokyo | METHOD FOR PRODUCING (GAMMA) -GLOBULIN FOR INTRAVENOUS INJECTION AND THERAPEUTIC AGENT WHICH CONTAINS THE SAME |
Also Published As
Publication number | Publication date |
---|---|
DE1148037B (en) | 1963-05-02 |
FR1560201A (en) | 1969-03-21 |
FR2382M (en) | 1964-03-09 |
CH397151A (en) | 1965-08-15 |
SE308367B (en) | 1969-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1104497A (en) | Recovery of spent etchants | |
ATA487174A (en) | PROCESS AND APPARATUS FOR THE PRODUCTION OF SUBSTANTIALLY WATER-INSOLUBLE, CHAIN-FORMED AMMONIUM POLYPHOSPHATES | |
GB1011013A (en) | Disaggregated gamma globulin and process for preparing it | |
GB1456275A (en) | Process of preparing an ointment | |
CH413738A (en) | Process for the treatment of aqueous slurries of flocculated or agglomerated amorphous organic solids | |
GB1430885A (en) | Process for preparing a purified extract of quillaia bark | |
GB1062434A (en) | Process for isolating -antitrypsin | |
ES273418A1 (en) | Procedure for the obtaining of unagregated gammaglobulin (Machine-translation by Google Translate, not legally binding) | |
CH393344A (en) | Process for the preparation of derivatives of 2-mercapto-4,6-bis-amino-s-triazine | |
GB1190682A (en) | Concentration of Aqueous Formaldehyde Solutions. | |
GB950774A (en) | The production of cerium (iv) molybdate, tungstate and vanadate | |
GB1300850A (en) | Method of separating leucocytes from whole blood | |
GB1313921A (en) | Process for preparation of sterile lecithin | |
AT240807B (en) | Method and device for the production of dimensionally stable and crease-resistant fabrics | |
CH423749A (en) | Process for the production of substituted ureas or thioureas | |
KR830004206A (en) | Method for Purifying Isoleucine | |
GB1046730A (en) | Treatment of honey and similar substances | |
CH438341A (en) | Process for the preparation of derivatives of 2-mercapto-4,6-bis amino-s-triazine | |
AT249883B (en) | Process for the preparation of corticosteroids substituted on the 21 carbon atom by piperazine derivatives | |
DE949252C (en) | Process for the isolation of antitoxins and related proteins | |
ATE90206T1 (en) | METHOD FOR INACTIVATING HEAT-SENSITIVE PATHOGENIC BLOOD-CARRIED VIRUSES IN IGG PREPARATIONS. | |
SU704621A1 (en) | Method of treating disturbances of functional state of the liver with massive blood transfusion syndrome | |
GB1207477A (en) | Plasma proteins solution | |
AT295474B (en) | Process for the production of high-resistance, semi-insulating gallium arsenide | |
SE300867B (en) |